However, non-tumor lung expression of miR-21, PTEN, MARCKs, TPM-1, PDCD4, and SPRY-2 did not significantly differ between LC-COPD and LC patients (Fig. 1a and Table 2). This evidence concerns the gene SPRY2 and laryngotracheoesophageal cleft.